C
Theravance Biopharma, Inc. TBPH
$16.48 -$0.04-0.24% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Total Cash And Short-Term Investments 201.61% 256.94% 260.85% 252.63% 30.89%
Total Receivables 1.50% 39.60% 8.44% 53.29% 4.70%
Inventory -- -- -- -- --
Prepaid Expenses 82.05% 76.85% -18.42% -37.61% -57.99%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 177.93% 159.80% 204.51% 207.02% 20.89%

Total Current Assets 177.93% 159.80% 204.51% 207.02% 20.89%
Net Property, Plant & Equipment -17.17% -15.39% -14.59% -17.08% -21.83%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -83.55% -83.65% -87.15% -86.88% -21.72%
Total Assets 37.47% 37.10% 16.67% 17.68% -7.47%

Total Accounts Payable -54.32% 14.54% 52.20% 0.06% 42.82%
Total Accrued Expenses 17.71% 46.87% 78.89% 45.47% 31.95%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -0.51% 2.18% 160.10% 158.26% 165.99%
Total Finance Division Other Current Liabilities -9.67% -9.67% -37.23% 311.34% -9.82%
Total Other Current Liabilities -9.67% -9.67% -37.23% 311.34% -9.82%
Total Current Liabilities 0.87% 19.38% 59.62% 138.09% 45.43%

Total Current Liabilities 0.87% 19.38% 59.62% 138.09% 45.43%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -20.34% -18.79% -17.42% -16.21% -14.81%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 10.52% 10.58% 5.14% 7.81% 7.74%
Total Liabilities 2.32% 5.73% 7.23% 19.51% 6.71%

Common Stock & APIC 0.88% 1.33% 1.56% 1.60% 1.72%
Retained Earnings 11.70% 10.97% 3.09% 1.39% -6.34%
Treasury Stock & Other -- 771.43% -36.00% 54.55% --
Total Common Equity 75.07% 69.03% 25.33% 16.09% -18.98%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 75.07% 69.03% 25.33% 16.09% -18.98%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 75.07% 69.03% 25.33% 16.09% -18.98%